Recombinant Human Growth Hormone
Growth hormone has been in the news recently because of accusations of criminal misconduct in some marketing and prescribing practices (G Kolata, New York Times, August 15, 1994, page 1). The high cost of the drug and its widespread use for unauthorized indications apparently were contributing factors....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Recombinant Human Growth Hormone
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 930
Article Code: 930a
Date: September 2, 1994
Volume: 36
Pages: 77-78
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 930
Article Code: 930a
Date: September 2, 1994
Volume: 36
Pages: 77-78
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)